BioArctic ABBRCTF 84 Days Payable is 112.09 as of Mar. 2026, which is 33% above its 10-year median of 84.22. GuruFocus rates BRCTF with a GF Score™ of 84/100 and a GF Value™ of $49.38 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 704 Biotechnology companies, BioArctic AB ranks better than 63.35% on this metric.
The historical rank and industry rank for BioArctic AB's Days Payable or its related term are showing as below:
BRCTF'
s Days Payable Range Over the Past 10 Years
Min: 28.12 Med: 84.22 Max: 9884.91
Current: 201.69
During the past 11 years, BioArctic AB's highest Days Payable was 9884.91. The lowest was 28.12. And the median was 84.22.
BRCTF's Days Payable is ranked better than 63.35% of 704
companies
in the Biotechnology industry
Industry Median: 113.56
vs BRCTF: 201.69
BioArctic AB's Days Payable
declined
from Mar. 2025 (371.22) to Mar. 2026 (112.09).
It may suggest that BioArctic ABaccelerated paying its suppliers.
BioArctic AB Days Payable Related Terms
BioArctic AB Days Payable Historical Data
* Premium members only.
The historical data trend for BioArctic AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BRCTF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, BioArctic AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioArctic AB Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioArctic AB's Days Payable distribution charts can be found below:
* The bar in red indicates where BioArctic AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BioArctic AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioArctic AB (BRCTF) has a Days Payable of 112.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioArctic AB and its competitors. This is 33% above median its historical median of 84.22. Over the past decade, BioArctic AB's Days Payable has ranged from 28.12 to 9,884.91. According to the industry distribution chart, BioArctic AB ranks #258 out of 704 companies in the Biotechnology industry, placing it in the top 36.6%.
Is BioArctic AB's Days Payable too high?
BioArctic AB's current Days Payable of 112.09 is 33% above median its 10-year median of 84.22. Over the past 10 years, this metric has ranged from a low of 28.12 to a high of 9,884.91. The Biotechnology industry median Days Payable is 113.56. BioArctic AB's value of 112.09 is 1.3% below this industry median. Based on the distribution chart, BioArctic AB ranks #258 out of 704 companies in the Biotechnology industry, which is above the industry midpoint. Overall, BioArctic AB has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioArctic AB ranks #258 out of 704 companies for Days Payable. This puts BioArctic AB in the upper half of its industry. The industry median Days Payable is 113.56. BioArctic AB's value of 112.09 is 1.3% below this benchmark. Historically, BioArctic AB's own Days Payable has ranged from 28.12 to 9,884.91 over the past decade. While the company's 10-year median is 84.22 vs. the industry median of 113.56, BioArctic AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioArctic AB's current Days Payable of 112.09 is 1.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioArctic AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioArctic AB's current Days Payable is 112.09, which is 33% above median its own 10-year median of 84.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (BRCTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $49.38, compared to a current price of $35.00 — trading 29.1% below its estimated fair value. The current Days Payable is 112.09, which is 33% above median its 10-year median of 84.22 and 1.3% below the Biotechnology industry median of 113.56. BioArctic AB's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BioArctic AB (BRCTF), the current Days Payable is 112.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioArctic AB (BRCTF) Overvalued in 2026?
Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued.
The current stock price of $35.00 is trading 29.1% below its estimated GF Value™ of $49.38.
GuruFocus considers BioArctic AB to be Modestly Undervalued.
Key valuation signals for BRCTF:
Days Payable: 112.09 (33% above median its 10-year median of 84.22)
GF Value™: $49.38 vs. price of $35.00 (29.1% below fair value)
Industry Position: 1.3% below the Biotechnology median (#258 of 704)
No single metric tells the full story. See the BRCTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
84GF Score
Get the complete analysis for BRCTF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCTF has been successfully added to your 
